Internal en bloc resection and genetic analysis of retinal capillary hemangioblastoma

Archives of Ophthalmology

Volumn 125, Issue 9, 2007, Pages 1189-1193

  Schlesinger, Thomas ^a,d   Appukuttan, Binoy ^a   Hwang, Thomas ^a   Atchaneeyakasul, La Ongsri ^a   Chan, Chi Chao ^b   Zhuang, Zhengping ^c   Stout, J Timothy ^a   Wilson, David J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; GENE; GENE MUTATION; HEMANGIOBLASTOMA; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA SURGERY; RETINA TUMOR; VHL GENE; VISUAL ACUITY;

ADOLESCENT; ADULT; DNA, NEOPLASM; HEMANGIOBLASTOMA; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; POLYMERASE CHAIN REACTION; RETINAL NEOPLASMS; RETROSPECTIVE STUDIES; VISUAL ACUITY; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 34548624380     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.9.1189     Document Type: Article

References (28)

1. Singh A, Shields JA, Shields CL. Solitary retinal capillary hemangioma: hereditary (von Hippel-Lindau disease) or non-hereditary [a published correction appears in Arch Ophthalmol. 2001;119(8):1226]? Arch Ophthalmol. 2001;119(2):232-234.
2. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260(5112):1317-1320.
3. Stratmann R, Krieg M, Haas R, Plate KH. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene. J Neuropathol Exp Neurol. 1997;56(11):1242-1252.
4. Iliopoulos O, Levy AP, Jiang C, Kaelin WG, Goldberg MA. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A. 1996;93(20):10595-10599.
5. Min JH, Yang H, Ivan M, Gertler F, Kaelin WG, Pavletich NP. Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling [published online ahead of print May 9, 2002]. Science. 2002;296(5574):1886-1889.
6. Hon WC, Wilson MI, Harlos K, et al. Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL [published online ahead of print June 5, 2002]. Nature. 2002;417(6892):975-978.
7. Annesley WJ Jr, Leonard BC, Shields JA, Tasman WS. Fifteen year review of treated cases of retinal angiomatosis. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83(3, pt 1):OP446-OP453.
8. Lane CM, Turner G, Gregor DJ, Bird AC. Laser treatment of retinal angiomatosis. Eye. 1989;3(pt 1):33-38.
9. Welch RB. von Hippel-Lindau disease: the recognition and treatment of early angiomatosis retinae and the use of cryosurgery as an adjunct to therapy. Trans Am Ophthalmol Soc. 1970;68:367-424.
10. Kreusel KM, Bornfeld N, Lommatzsch A, et al. Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology. 1998;105(8):1386-1392.
11. Raja D, Benz MS, Murray TG, Escalona-Benz EM, Markoe A. Salvage external beam radiotherapy of retinal capillary hemangiomas secondary to von Hippel-Lindau disease: visual and anatomic outcomes. Ophthalmology. 2004;111(1):150-153.
12. Mochizuki Y, Noda Y, Enaida H, et al. Retinal capillary hemangioma managed by transpupillary thermotherapy. Retina. 2004;24(6):981-984.
13. Bakri SJ, Sears JE, Singh AD. Transient closure of a retinal capillary hemangioma with verteporfin photodynamic therapy. Retina. 2005;25(8):1103-1104.
14. Szabó A, Gehl Z, Seres A. Photodynamic (verteporfin) therapy for retinal capillary haemangioma, with monitoring of feeder and draining blood vessel diameters. Acta Ophthalmol Scand. 2005;83(4):512-513.
15. Aaberg TM Jr, Aaberg TM Sr, Martin DF, Gilman JP, Myles R. Three cases of large retinal capillary hemangiomas treated with verteporfin and photodynamic therapy. Arch Ophthalmol. 2005;123(3):328-332.
16. Girmens JF, Erginay A, Massin P, Scigalla P, Gaudric A, Richard S. Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. Am J Ophthalmol. 2003;136(1):194-196.
17. Aiello LP, George DJ, Cahill MT, et al. Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor SU5416. Ophthalmology. 2002;109(9):1745-1751.
18. Maher ER, Yates JR, Harries R, et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990;77(283):1151-1163.
19. Vortmeyer AO, Gnarra JR, Emmert-Buck MR, et al. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol. 1997;28(5):540-543.
20. Zhuang Z, Bertheau P, Emmert-Buck MR, et al. A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1mm in size. Am J Pathol. 1995;146(3):620-625.
21. Chan CC, Vortmeyer AO, Chew EY, et al. VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma. Arch Ophthalmol. 1999;117(5):625-630.
22. Chan CC, Lee YS, Zhuang Z, Hackett J, Chew EY. von Hippel-Lindau gene deletion and expression of hypoxia-inducible factor and ubiquitin in optic nerve hemangioma. Trans Am Ophthalmol Soc. 2004;102:75-81.
23. Peyman GA, Rednam KR, Mottow-Lippa L, Flood T. Treatment of large von Hippel tumors by eye wall resection. Ophthalmology. 1983;90(7):840-847.
24. Farah ME, Uno F, Hofling-Lima AL, et al. Transretinal feeder vessel ligature in von Hippel-Lindau disease. Eur J Ophthalmol. 2001;11(4):386-388.
25. Fisher PG, Tontiplaphol A, Pearlman EM, et al. Childhood cerebellar hemangioblastoma does not predict germline or somatic mutations in the von Hippel-Lindau tumor suppressor gene. Ann Neurol. 2002;51(2):257-260.
26. Lee JY, Dong SM, Park WS, et al. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res. 1998;58(3):504-508.
27. Oberstrass J, Reifenberger G, Reifenberger J, Wechsler W, Collins VP. Mutation of the von Hippel-Lindau tumour suppressor gene in capillary hemangioblastomas of the central nervous system. J Pathol. 1996;179(2):151-156.
28. Kanno H, Kondo K, Ito S, Yamamoto I. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res. 1994;54(18):4845-4847.